Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc. [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
is increasing the frequency of these diseases and favorably boosting the liposomal doxorubicin market growth. NEWARK, Del, July 03, 2024 (GLOBE NEWSWIRE) -- The liposomal doxorubicin market is estimated to be worth USD 1,281.3 Million in 2024 and is projected to be valued at USD 2,367.5 Million in 2034. Between 2024 and 2034, the industry is expected to register a growth rate of 6.3%. The increasing prevalence of diverse cancer types, such as breast cancer, ovarian cancer, and Kaposi's sarcoma, is a key factor driving the demand for potent chemotherapy medications like liposomal doxorubicin. The anticipated growth in the sales of liposomal doxorubicin is influenced by pivotal factors, including the contemporary lifestyle characterized by fast-paced routines and unhealthy dietary habits, leading to a spectrum of health concerns over the forecasted period. Anticipated drivers set to propel the expansion of the liposomal doxorubicin market include the growing utilization of chemother
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Dupixent “addresses current gap” in COPD biologics landscape [Yahoo! Finance]Yahoo! Finance
- Three Solid Euronext Paris Dividend Stocks With Yields Up To 7.9% [Yahoo! Finance]Yahoo! Finance
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit [Yahoo! Finance Canada]Yahoo! Finance Canada
- French State Investment Firm Eyes Stake in Sanofi Consumer Unit [BNN Bloomberg (Canada)]BNN Bloomberg
- Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal Calculi Retrieval Devices Landscape | TMR [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 7/2/24 - Form 6-K
- 6/28/24 - Form 11-K
- 6/28/24 - Form 11-K
- SNY's page on the SEC website